Age-related hearing loss and its potential drug candidates: a systematic review

Shiyu Hu, Qingru Sun, Fei Xu, Ning-Hua Jiang, Jian‐Li GaoChinese 2023 · DOI

Abstract

Age-related hearing loss (ARHL) is one of the main illnesses afflicting the aged population and has a significant negative impact on society, economy, and health. However, there is presently no appropriate therapeutic treatment of ARHL due to the absence of comprehensive trials. This review systematically evaluates and analyzes recent statistics on the pathologic classifications, risk factors, treatment strategies, and drug candidates of ARHL, including those from traditional Chinese medicine (TCM). Results indicate that many hypotheses about the etiology of ARHL are based on genetic and environmental elements, focusing on oxidative damage, mitochondrial dysfunction, inflammation, and ion homeostasis. In TCM, herbs belonging to the kidney, lung, and liver meridians exhibit good hearing protection. Active compounds like ginsenoside Rb1 and puerarin show anti-oxidative, neuroprotective, and anti-inflammatory effects, suggesting that herbs are an important source of potential anti-ARHL drugs.

Introduction

Age-related hearing loss (ARHL), or presbycusis, affects over 1.5 billion people globally. As the third most common chronic health condition in older adults, it significantly impacts cognitive health, social engagement, and overall quality of life. Despite its high prevalence, clinical management is currently limited to mechanical aids such as hearing aids and cochlear implants, as no FDA-approved pharmacological treatments exist. This systematic review addresses the gap between our growing understanding of auditory pathology and the lack of effective drugs by synthesizing data from major databases including PubMed, Web of Science, CNKI, and Wanfang.

Pathological Classifications of ARHL

ARHL is not a monolithic condition but rather a complex set of pathologies. It is generally categorized into four distinct types based on the site of damage within the auditory system:

  • Sensory Presbycusis: Characterized by the degeneration of hair cells (HCs) in the organ of Corti.
  • Neural Presbycusis: Involves the loss of spiral ganglion neurons (SGNs) and auditory nerve fibers.
  • Metabolic (Striatal) Presbycusis: Results from atrophy of the stria vascularis, which is essential for maintaining the endocochlear potential.
  • Central Presbycusis: Involves dysfunction in the central auditory pathways and nuclei.
Anatomical mapping of the auditory pathway and the four primary types of presbycusis.

Genetic Drivers of Hearing Loss

Genetic predisposition plays a critical role in susceptibility to ARHL. The Ahl (age-related hearing loss) gene is a primary driver, particularly affecting the health of hair cells. Other genes, such as GJB2 (encoding Cx26) and KCNQ4, are vital for maintaining ion homeostasis and cochlear amplification. Mutations in these genes can lead to elevated hearing thresholds and accelerated degeneration of the inner ear structures.

Summary of genetic factors and related mechanisms contributing to age-related hearing loss.

Potential Therapeutic Candidates

Research into pharmacological interventions focuses on several key mechanisms: oxidative stress, mitochondrial dysfunction, and inflammation.

Synthetic and Natural Compounds

  • Antioxidants: Compounds like Resveratrol and NRH activate SIRT1 to protect hair cells from oxidative damage.
  • Vasodilators: Magnesium ($Mg^{2+}$) and histamine derivatives improve cochlear blood flow, which often diminishes with age.
  • Neurotrophic Factors: Nerve Growth Factor (NGF) and IGF-1 show promise in regenerating or protecting spiral ganglion neurons.

Traditional Chinese Medicine (TCM)

In TCM theory, the "Kidney opens into the ear," and this review finds empirical support for the otoprotective effects of herbs traditionally associated with the Kidney, Lung, and Liver meridians. Unlike many synthetic drugs that target a single receptor, these herbal compounds often exhibit pleiotropic effects:

  • Ginsenoside Rb1: Reduces reactive oxygen species (ROS) production and inhibits JNK-mediated apoptosis.
  • Puerarin: Improves auditory brainstem response (ABR) thresholds and modulates neurotransmitter receptors (GABA).
  • THSG (from Polygonum multiflorum): Acts as a potent antioxidant and anti-inflammatory agent.

Limitations and Future Directions

While the discovery of these potential drug candidates is promising, several hurdles remain. Most research is currently limited to in vitro or animal models, and large-scale human clinical trials are urgently needed. Furthermore, the standardization of herbal medicines—ensuring consistent concentrations of active ingredients—remains a challenge. Future research may also explore "cell replacement therapy" using induced pluripotent stem cells to regenerate lost hair cells, alongside the continued validation of TCM-derived small molecules.

Summary updated

Abstract

Abstract Background Age-related hearing loss (ARHL) is one of the main illnesses afflicting the aged population and has a significant negative impact on society, economy, and health. However, there is presently no appropriate therapeutic treatment of ARHL due to the absence of comprehensive trials. Objectives The goal of this review is to systematically evaluate and analyze recent statistics on the pathologic classifications, risk factors, treatment strategies, and drug candidates of ARHL, including that from traditional Chinese medicine (TCM), to provide potential new approaches for preventing and treating ARHL. Methods Literature related to ARHL was conducted in databases such as PubMed, WOS, China National Knowledge Infrastructure (CNKI), and Wanfang from the establishment of the database to Jan, 2023. The pathology, causal factor, pathophysiological mechanism, treatment strategy, and the drug candidate of ARHL were extracted and pooled for synthesis. Results Many hypotheses about the etiology of ARHL are based on genetic and environmental elements. Most of the current research on the pathology of ARHL focuses on oxidative damage, mitochondrial dysfunction, inflammation, cochlear blood flow, ion homeostasis, etc. In TCM, herbs belonging to the kidney, lung, and liver meridians exhibit good hearing protection. Seven herbs belonging to the kidney meridian, 9 belonging to the lung meridian, and 4 belonging to the liver meridian were ultimately retrieved in this review, such as Polygonum multiflorum Thunb., Panax ginseng C.A. Mey, and Pueraria lobata (Willd.) Ohwi. Their active compounds, 2,3,4',5-Tetrahydroxystilbene-2-O-D-glucoside, ginsenoside Rb1, and puerarin, may act as the molecular substance for their anti-ARHL efficacy, and show anti-oxidative, neuroprotective, anti-inflammatory, anti-apoptotic, or mitochondrial protective effects. Conclusion Anti-oxidants, modulators of mitochondrial function, anti-inflammation agents, vasodilators, K + channel openers, Ca 2+ channel blockers, JNK inhibitors, and nerve growth factors/neurotrophic factors all contribute to hearing protection, and herbs are an important source of potential anti-ARHL drugs.
BibTeX
@inproceedings{hu2023age,
  author = {Shiyu Hu and Qingru Sun and Fei Xu and Ning-Hua Jiang and Jian‐Li Gao},
  title = {{Age-related hearing loss and its potential drug candidates: a systematic review}},
  booktitle = {Chinese},
  year = {2023},
  doi = {10.1186/s13020-023-00825-6},
}
Figure